Glycogen Storage Disease
Rare Disease·MeSH: Glycogen Storage Disease
Prevalence
5.0 / 100K
8 drugs in development·5 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(4)
Phase 2(1)
| Drug | Company |
|---|---|
| alglucosidase alfa | Sanofi (SNY) |
Preclinical(1)
| Drug | Company |
|---|---|
| gsd1b program | Prime Medicine, Inc. (PRME) |
Unknown(1)
| Drug | Company |
|---|---|
| alglucosidase alfa gz419829 | Sanofi (SNY) |
Phase 4(1)
| Drug | Company |
|---|---|
| avalglucosidase alfa | Sanofi (SNY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Glycogen Storage Disease?
BioSniper tracks 8 drugs in development for Glycogen Storage Disease across 5 companies.
How many clinical trials target Glycogen Storage Disease?
There are 2 clinical trials targeting Glycogen Storage Disease tracked by BioSniper.
What is the prevalence of Glycogen Storage Disease?
The estimated prevalence of Glycogen Storage Disease is approximately 5.0 per 100,000 population.
Deep-dive into Glycogen Storage Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis